ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,735,000 | -84.4% | 441,088 | -82.1% | 0.60% | -83.6% |
| Q1 2019 | $17,561,000 | -21.3% | 2,469,894 | -5.5% | 3.63% | +23.5% |
| Q4 2018 | $22,328,000 | -16.0% | 2,614,468 | +96.8% | 2.94% | -25.0% |
| Q3 2018 | $26,595,000 | -27.3% | 1,328,424 | -6.3% | 3.91% | -32.1% |
| Q2 2018 | $36,604,000 | +34.9% | 1,417,121 | +24.8% | 5.76% | +36.3% |
| Q1 2018 | $27,131,000 | – | 1,135,203 | – | 4.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |